CDKN3 Produits
(Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories CDKN3 en vedette
CDKN3 Anticorps
High quality antibodies with extensive validation data.
CDKN3 Kits ELISA
Reliable ELISA kits for a wide range of species.
CDKN3 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
CDKN3 recommandé Anticorps
- (4)
- (3)
- (2)
CDKN3 recommandé Kits ELISA
- (1)
- (1)
CDKN3 recommandé Protéines
- (1)
- (1)
- (1)
Dernières publications sur nos produits CDKN3
: "High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer." dans: International journal of cancer. Journal international du cancer, Vol. 126, Issue 5, pp. 1263-74, (2010) (PubMed).: "An approach based on a genome-wide association study reveals candidate loci for narcolepsy." dans: Human genetics, Vol. 128, Issue 4, pp. 433-41, (2010) (PubMed).
: "KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction." dans: Biochemical and biophysical research communications, Vol. 351, Issue 1, pp. 216-22, (2006) (PubMed).
: "Transcriptional repression activity of PAX3 is modulated by competition between corepressor KAP1 and heterochromatin protein 1." dans: Biochemical and biophysical research communications, Vol. 349, Issue 2, pp. 573-81, (2006) (PubMed).
: "Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP..." dans: The Journal of biological chemistry, Vol. 280, Issue 17, pp. 17235-42, (2005) (PubMed).
: "Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant." dans: Biochemical and biophysical research communications, Vol. 305, Issue 2, pp. 311-4, (2003) (PubMed).
: "Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression." dans: Molecular and cellular biology, Vol. 20, Issue 5, pp. 1723-32, (2000) (PubMed).
: "Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma." dans: Cancer research, Vol. 60, Issue 17, pp. 4697-700, (2000) (PubMed).
Synonymes et noms alternatifs relatifs à CDKN3
cyclin dependent kinase inhibitor 3 (CDKN3), cyclin-dependent kinase inhibitor 3 (CDKN3), cyclin-dependent kinase inhibitor 3 (cdkn3), cyclin-dependent kinase inhibitor 3 (Cdkn3), cyclin dependent kinase inhibitor 3 (Cdkn3), inhibitor/interactor with cyclin-dependent kinase (ICK6), 2410006H10Rik, CDI1, CDKN3, CIP2, inhibitor/interactor with cyclin-dependent kinase, K24G6.15, K24G6_15, KAP, KAP1, KIP-RELATED PROTEIN 3, KRP3Protein level used designations for CDKN3
- CDK2-associated dual specificity phosphatase
- CDK2-associated dual-specificity phosphatase
- Cdk-associated protein phosphatase
- cyclin-dependent kinase interacting protein 2
- cyclin-dependent kinase interactor 1
- cyclin-dependent kinase-interacting protein 2
- kinase associated phosphatase
- kinase-associated phosphatase
- cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)
- cyclin-dependent kinase inhibitor 3
- Kinase-associated phosphatase
- Inhibitor/interactor of CDK protein 6
- KIP-related protein 3